Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation
暂无分享,去创建一个
Hui Yang | Xiaoying Ye | Lingbo Wang | Xiaoying Ye | Hui Yang | Lin Liu | Man Zhang | Jingjing Jiang | Wenjian Lv | Chikai Zhou | Man Zhang | Maja Okuka | Jing Jiang | Xuan Zhang | Jinsong Li | Wenjian Lv | Lin Liu | Maja Okuka | Jinsong Li | Chikai Zhou | Lingbo Wang | Xuan Zhang
[1] Sheng Ding,et al. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. , 2010, Trends in pharmacological sciences.
[2] P. Klatt,et al. Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres , 2007, The Journal of cell biology.
[3] Scott W. Lowe,et al. Stem cells: The promises and perils of p53 , 2009, Nature.
[4] Shaorong Gao,et al. Cell Stem Cell Brief Report Ips Cells Can Support Full-term Development of Tetraploid Blastocyst-complemented Embryos Cell Stem Cell Brief Report , 2022 .
[5] Riitta Lahesmaa,et al. Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.
[6] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[7] K. Caldecott,et al. DNA strand break repair and human genetic disease. , 2007, Annual review of genomics and human genetics.
[8] Krishanu Saha,et al. Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.
[9] Yves Pommier,et al. γH2AX and cancer , 2008, Nature Reviews Cancer.
[10] K. Hochedlinger,et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.
[11] Yutao Du,et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. , 2012, Cell stem cell.
[12] P. Mombaerts,et al. Nuclear Transfer-Mediated Rescue of the Nuclear Genome of Nonviable Mouse Cells Frozen Without Cryoprotectant , 2008, Biology of reproduction.
[13] H. Lewin,et al. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning , 2007, Nature Genetics.
[14] D. Keefe,et al. Association of telomere length with authentic pluripotency of ES/iPS cells , 2011, Cell Research.
[15] R. Stewart,et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.
[16] Jennifer Nichols,et al. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.
[17] Qi Zhou,et al. iPS cells produce viable mice through tetraploid complementation , 2009, Nature.
[18] Martin J. Aryee,et al. Epigenetic memory in induced pluripotent stem cells , 2010, Nature.
[19] Geppino Falco,et al. An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. , 2008, Gene expression patterns : GEP.
[20] R. Jaenisch,et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] Richard A Young,et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. , 2008, Cell stem cell.
[22] T. Lange,et al. DNA Damage Foci at Dysfunctional Telomeres , 2003, Current Biology.
[23] María A Blasco,et al. Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.
[24] Richard J. Giannone,et al. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Hogendoorn,et al. Telomere‐associated proteins: cross‐talk between telomere maintenance and telomere‐lengthening mechanisms , 2009, The Journal of pathology.
[26] R. Jaenisch,et al. ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] Wenjun Guo,et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.
[28] Julie V. Harness,et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. , 2011, Cell stem cell.
[29] M. Atasoy,et al. The alteration of sister chromatid exchange frequencies in Behçet's disease with and without HLA‐B51 , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.
[30] Wenjun Guo,et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.
[31] M. Blasco,et al. Telomere lengthening early in development , 2007, Nature Cell Biology.
[32] G. Falco,et al. Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. , 2007, Developmental biology.
[33] Andrew P. Feinberg,et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.
[34] Yixue Li,et al. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies. , 2011, Journal of molecular cell biology.
[35] Geppino Falco,et al. Zscan4 regulates telomere elongation and genomic stability in ES cells , 2010, Nature.
[36] H. Schöler,et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.
[37] Devanshi Jain,et al. Telomeric strategies: means to an end. , 2010, Annual review of genetics.
[38] T. de Lange. How Telomeres Solve the End-Protection Problem , 2009, Science.
[39] Han-Woong Lee,et al. Dynamic rearrangement of telomeres during spermatogenesis in mice. , 2005, Developmental biology.
[40] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[41] T. T. Su. Cellular responses to DNA damage: one signal, multiple choices. , 2006, Annual review of genetics.
[42] M. Ko,et al. Zscan4 transiently reactivates early embryonic genes during the generation of induced pluripotent stem cells , 2012, Scientific Reports.
[43] M. Pera,et al. Stem cells: The dark side of induced pluripotency , 2011, Nature.
[44] Tomohiro Kono,et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.
[45] J. Bartek,et al. More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance , 2011, Nature Cell Biology.
[46] K. Hochedlinger,et al. Epigenetic reprogramming and induced pluripotency , 2009, Development.
[47] Yoav Mayshar,et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.
[48] Jiuhong Kang,et al. E‐Cadherin‐Mediated Cell–Cell Contact Is Critical for Induced Pluripotent Stem Cell Generation , 2010, Stem cells.
[49] H. Schöler,et al. p53 connects tumorigenesis and reprogramming to pluripotency , 2010, The Journal of experimental medicine.
[50] Uma Lakshmipathy,et al. Pluripotent Stem Cells , 2013, Methods in Molecular Biology.
[51] N. Benvenisty,et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.
[52] K. Hochedlinger,et al. Induced pluripotency: history, mechanisms, and applications. , 2010, Genes & development.
[53] E. Kirkness,et al. Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.
[54] S. Gagos,et al. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells , 2011, Cell Research.
[55] A. Consiglio,et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.
[56] M. Blasco,et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. , 2009, Cell stem cell.
[57] Stéphanie Boué,et al. Methods for making induced pluripotent stem cells: reprogramming à la carte , 2011, Nature Reviews Genetics.
[58] Manuel Serrano,et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.
[59] Mika Sato-llic,et al. for Dynamic Changes , 1998 .
[60] M. Kyba,et al. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. , 2012, Cell stem cell.
[61] S. Nishikawa,et al. Equivalency of Nuclear Transfer‐Derived Embryonic Stem Cells to Those Derived from Fertilized Mouse Blastocysts , 2006, Stem cells.
[62] G. Wahl,et al. Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.
[63] M. Araúzo-Bravo,et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors , 2008, Nature.